With the ease of online publishing, the number of journals has exploded, and with them the number of papers. It has gotten ...
New-generation GLP-1 drugs, such as retatrutide, are achieving higher rates of weight loss. How much weight is too much and ...
A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...
Clinical trials in China are getting attention at an international oncology gathering in Chicago. China’s surging biotechnology industry is fueling alarm that U.S. dominance in the field is waning.
When Shania Collins was first approached about taking performance-enhancing drugs last year, it made her nervous enough to ...
About 70,000 Americans died of drug overdoses last year — about 14% fewer than the previous year, according to preliminary government data. It was the third straight annual drop, making it the longest ...
Scientists at UC San Diego have unveiled a potentially game-changing treatment for MASH, a severe fatty liver disease ...
Several studies have served up tantalizing hints about the drugs’ potential cancer prevention benefits, but other results land all over the map.
While drugs such as Wegovy target a single gut hormone, retatrutide is among a new class of GLP-1 drugs that aims at three ...
Getting your Trinity Audio player ready... How do you talk to kids about drugs when telling them to ‘Just Say No’ might not work? Beyond sobriety In a three-part series, The Denver Post is exploring ...
Space-based drug labs are here! See how Varda and United Therapeutics are using microgravity to improve rare lung disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results